Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Metastatic choriocarcinoma presenting in a gravid woman.

Byrd K, Seay R, Bechert CJ, Maxwell GL, Bicher A.

Gynecol Obstet Invest. 2015;79(4):276-9. doi: 10.1159/000363234. Epub 2014 Nov 19.

PMID:
25412690
2.

Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988.

Reed E, Zerbe CS, Brawley OW, Bicher A, Steinberg SM.

Am J Clin Oncol. 2000 Apr;23(2):107-16.

PMID:
10776968
3.

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.

Yu JJ, Bicher A, Ma YK, Bostick-Bruton F, Reed E.

Cancer Lett. 2000 Apr 14;151(2):127-32.

PMID:
10738106
4.

Loss of heterozygosity in human ovarian cancer on chromosome 19q.

Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B.

Gynecol Oncol. 1997 Jul;66(1):36-40.

PMID:
9234918
5.

Infusion site soft-tissue injury after paclitaxel administration.

Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM.

Cancer. 1995 Jul 1;76(1):116-20.

PMID:
8630862
6.

Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy.

Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM.

Obstet Gynecol. 1995 May;85(5 Pt 1):735-9.

PMID:
7724104
7.

Metastatic cervical cancer presenting as cholecystitis.

Bicher A, Sahin AA, Burke TW.

Gynecol Oncol. 1994 Aug;54(2):250-3.

PMID:
8063256
8.

Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy.

Link CJ Jr, Bicher A, Kohn EC, Christian MC, Davis PA, Adamo DO, Reed E, Sarosy GA.

Blood. 1994 Mar 1;83(5):1188-92.

PMID:
7509652
9.

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, et al.

J Natl Cancer Inst. 1994 Jan 5;86(1):18-24.

PMID:
7505830
10.

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.

Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R, Muggia FM.

Cancer Res. 1993 Aug 15;53(16):3694-9.

11.

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor.

Bicher A, Kohn E, Sarosy G, Davis P, Adamo DO, Jacob J, Christian M, Reed E.

Anticancer Drugs. 1993 Apr;4(2):141-8.

PMID:
7683933
12.

Age does not influence taxol dose intensity in recurrent carcinoma of the ovary.

Bicher A, Sarosy G, Kohn E, Adamo DO, Davis P, Jacob J, Chabner BA, Reed E.

Cancer. 1993 Jan 15;71(2 Suppl):594-600.

PMID:
7678382

Supplemental Content

Loading ...
Support Center